183 related articles for article (PubMed ID: 29737462)
21. Performance of Diagnostic Scores in Thrombotic Microangiopathy Patients in the Intensive Care Unit: A Monocentric Study.
Mariotte E; Zafrani L; Fadlallah J; Galicier L; Ghrenassia E; Kerhuel L; Calvet L; Jong A; Lemiale V; Valade S; Joly BS; Stepanian A; Azoulay E; Darmon M
Thromb Haemost; 2021 Nov; 121(11):1427-1434. PubMed ID: 33512705
[TBL] [Abstract][Full Text] [Related]
22. Utility of Different Scoring Systems for the Diagnosis of Thrombotic Microangiopathies.
Yilmaz S; Cenelİ O; Tekinalp A
J Coll Physicians Surg Pak; 2023 May; 33(5):539-543. PubMed ID: 37190689
[TBL] [Abstract][Full Text] [Related]
23. Utilizing a PLASMIC score-based approach in the management of suspected immune thrombotic thrombocytopenic purpura: a cost minimization analysis within the Harvard TMA Research Collaborative.
Upadhyay VA; Geisler BP; Sun L; Uhl L; Kaufman RM; Stowell C; Makar RS; Bendapudi PK
Br J Haematol; 2019 Aug; 186(3):490-498. PubMed ID: 31131442
[TBL] [Abstract][Full Text] [Related]
24. Comparison of Clinical Scoring Systems in the Management of Patients with Microangiopathic Hemolytic Anemia and Thrombocytopenia.
Baysal M; Ümit E; Kırkızlar HO; Demir AM
Turk J Haematol; 2021 Feb; 38(1):64-68. PubMed ID: 33161686
[TBL] [Abstract][Full Text] [Related]
25. Development and validation of a multivariable prediction rule for detecting a severe acquired ADAMTS13 activity deficiency in patients with thrombotic microangiopathies.
Nieto JM; De La Fuente-Gonzalo F; González FA; Villegas A; Martínez R; Fuentes ME; Ropero P
Clin Chem Lab Med; 2018 Jan; 56(2):294-302. PubMed ID: 28796639
[TBL] [Abstract][Full Text] [Related]
26.
Kim Y; Ahn A; Lee JM; Kim M; Lee HK; Kim H
Ann Clin Lab Sci; 2024 Mar; 54(2):265-269. PubMed ID: 38802156
[No Abstract] [Full Text] [Related]
27. Application of PLASMIC score in prediction of ADAMTS13 deficiency in a pediatric case of acquired thrombotic thrombocytopenic purpura.
Gupta GK; Hendrickson JE; Tormey CA
J Clin Apher; 2020 Apr; 35(2):140-141. PubMed ID: 31951292
[No Abstract] [Full Text] [Related]
28. Potential modifications of the PLASMIC scoring system for predicting thrombotic thrombocytopenic purpura: Sometimes, less is more.
Orhan B; Özkocaman V; Akdemir Ç; Ersal T; Pınar İE; Yalçın C; Candar Ö; Çubukçu S; Koca TG; Ambarcıoğlu P; Ali R; Özkalemkaş F
Int J Lab Hematol; 2023 Oct; 45(5):751-757. PubMed ID: 37309683
[TBL] [Abstract][Full Text] [Related]
29. The use of ADAMTS13 activity, platelet count, and serum creatinine to differentiate acquired thrombotic thrombocytopenic purpura from other thrombotic microangiopathies.
Cataland SR; Yang S; Wu HM
Br J Haematol; 2012 May; 157(4):501-3. PubMed ID: 22296585
[No Abstract] [Full Text] [Related]
30. [Clinical observation of a patient with thrombotic thrombocytopenic purpura with renal and intestinal lesions].
Stolyar AG; Avdonin PV; Valamina IE; Stolyarevich ES
Ter Arkh; 2019 Jul; 91(7):106-110. PubMed ID: 32598743
[TBL] [Abstract][Full Text] [Related]
31. Complement activation, inflammation and relative ADAMTS13 deficiency in secondary thrombotic microangiopathies.
Farkas P; Csuka D; Mikes B; Sinkovits G; Réti M; Németh E; Rácz K; Madách K; Gergely M; Demeter J; Prohászka Z
Immunobiology; 2017 Feb; 222(2):119-127. PubMed ID: 27771173
[TBL] [Abstract][Full Text] [Related]
32. Plasmic score applicability for the diagnosis of thrombotic microangiopathy associated with ADAMTS13-acquired deficiency in a developing country.
Oliveira DS; Lima TG; Benevides FLN; Barbosa SAT; Oliveira MA; Boris NP; Silva HF
Hematol Transfus Cell Ther; 2019; 41(2):119-124. PubMed ID: 31079658
[TBL] [Abstract][Full Text] [Related]
33. Cost-effectiveness of rapid vs in-house vs send-out ADAMTS13 testing for immune thrombotic thrombocytopenic purpura.
Allen C; Ito S; Butt A; Purcell A; Richmond R; Tormey CA; Krumholz HM; Cuker A; Goshua G
Blood Adv; 2024 May; 8(9):2279-2289. PubMed ID: 38502197
[TBL] [Abstract][Full Text] [Related]
34. Clinical features and outcomes in patients with thrombotic microangiopathy not associated with severe ADAMTS13 deficiency.
Li A; Bendapudi PK; Uhl L; Hamdan A; Kaufman RM; Makar RS
Transfusion; 2017 Sep; 57(9):2151-2158. PubMed ID: 28635017
[TBL] [Abstract][Full Text] [Related]
35. Treatment with or without plasma exchange for patients with acquired thrombotic microangiopathy not associated with severe ADAMTS13 deficiency: a propensity score-matched study.
Li A; Makar RS; Hurwitz S; Uhl L; Kaufman RM; Stowell CP; Dzik WS; Bendapudi PK
Transfusion; 2016 Aug; 56(8):2069-77. PubMed ID: 27232383
[TBL] [Abstract][Full Text] [Related]
36. Distinguishing and overlapping laboratory results of thrombotic microangiopathies in HIV infection: Can scoring systems assist?
Louw S; Jacobson BF; Mayne ES
J Clin Apher; 2022 Oct; 37(5):460-467. PubMed ID: 36054148
[TBL] [Abstract][Full Text] [Related]
37. The use of ADAMTS13 assays in thrombotic microangiopathies.
Cataland S
Clin Adv Hematol Oncol; 2021 Nov; 19(11):687-689. PubMed ID: 34807013
[No Abstract] [Full Text] [Related]
38. Development and validation of a predictive model for death in acquired severe ADAMTS13 deficiency-associated idiopathic thrombotic thrombocytopenic purpura: the French TMA Reference Center experience.
Benhamou Y; Assié C; Boelle PY; Buffet M; Grillberger R; Malot S; Wynckel A; Presne C; Choukroun G; Poullin P; Provôt F; Gruson D; Hamidou M; Bordessoule D; Pourrat J; Mira JP; Le Guern V; Pouteil-Noble C; Daubin C; Vanhille P; Rondeau E; Palcoux JB; Mousson C; Vigneau C; Bonmarchand G; Guidet B; Galicier L; Azoulay E; Rottensteiner H; Veyradier A; Coppo P;
Haematologica; 2012 Aug; 97(8):1181-6. PubMed ID: 22580997
[TBL] [Abstract][Full Text] [Related]
39. Plasmin cleavage of von Willebrand factor as an emergency bypass for ADAMTS13 deficiency in thrombotic microangiopathy.
Tersteeg C; de Maat S; De Meyer SF; Smeets MW; Barendrecht AD; Roest M; Pasterkamp G; Fijnheer R; Vanhoorelbeke K; de Groot PG; Maas C
Circulation; 2014 Mar; 129(12):1320-31. PubMed ID: 24449821
[TBL] [Abstract][Full Text] [Related]
40. Predictive features of severe acquired ADAMTS13 deficiency in idiopathic thrombotic microangiopathies: the French TMA reference center experience.
Coppo P; Schwarzinger M; Buffet M; Wynckel A; Clabault K; Presne C; Poullin P; Malot S; Vanhille P; Azoulay E; Galicier L; Lemiale V; Mira JP; Ridel C; Rondeau E; Pourrat J; Girault S; Bordessoule D; Saheb S; Ramakers M; Hamidou M; Vernant JP; Guidet B; Wolf M; Veyradier A;
PLoS One; 2010 Apr; 5(4):e10208. PubMed ID: 20436664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
